Hong Y - Search Results

1

Short-chain fatty acid-butyric acid ameliorates granulosa cells inflammation through regulating METTL3-mediated N6-methyladenosine modification of FOSL2 in polycystic ovarian syndrome.

Liu K, He X, Huang J, Yu S, Cui M, Gao M, Liu L, Qian Y, Xie Y, Hui M, Hong Y, Nie X. Liu K, et al. Among authors: hong y. Clin Epigenetics. 2023 May 13;15(1):86. doi: 10.1186/s13148-023-01487-9. Clin Epigenetics. 2023. PMID: 37179374 Free PMC article.

2

[Effect of electro-acupuncture on clinical outcomes and ovarian hyperstimulation syndrome in in vitro fertilization and embryo transplantation].

Hong YL, Tan Y, Yin YY, Zou YJ, Guo YH, Nie XW. Hong YL, et al. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014 Nov;34(11):1292-6. Zhongguo Zhong Xi Yi Jie He Za Zhi. 2014. PMID: 25566616 Chinese.

3

Serum metabolomics reveals metabolic profiling for women with hyperandrogenism and insulin resistance in polycystic ovary syndrome.

Zhang Z, Hong Y, Chen M, Tan N, Liu S, Nie X, Zhou W. Zhang Z, et al. Among authors: hong y. Metabolomics. 2020 Jan 24;16(2):20. doi: 10.1007/s11306-020-1642-y. Metabolomics. 2020. PMID: 31980950

4

Non-invasive urinary metabolomics reveals metabolic profiling of polycystic ovary syndrome and its subtypes.

Zhou W, Hong Y, Yin A, Liu S, Chen M, Lv X, Nie X, Tan N, Zhang Z. Zhou W, et al. Among authors: hong y. J Pharm Biomed Anal. 2020 Jun 5;185:113262. doi: 10.1016/j.jpba.2020.113262. Epub 2020 Mar 17. J Pharm Biomed Anal. 2020. PMID: 32222648

5

Serum-Derived Exosomal microRNAs in Lipid Metabolism in Polycystic Ovary Syndrome.

Hong Y, Wu J, Yu S, Hui M, Lin S. Hong Y, et al. Reprod Sci. 2022 Sep;29(9):2625-2635. doi: 10.1007/s43032-022-00930-1. Epub 2022 Aug 3. Reprod Sci. 2022. PMID: 35922742

6

Efficiency of Chinese medicine Bushen Huatan formula for treatment of polycystic ovary syndrome in mice via regulating gut microbiota and PPARγ pathway.

Cui M, Hong Y, Huang J, Liu K, Chen J, Tan Y, Nie X. Cui M, et al. Among authors: hong y. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023 Feb 25;52(1):33-45. doi: 10.3724/zdxbyxb-2022-0456. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2023. PMID: 37283116 Free PMC article. Chinese, English.

7

PAK2/beta-catenin/c-Myc/PKM2 signal transduction suppresses ovarian granulosa cell apoptosis in polycystic ovary syndrome.

Hui M, Hu S, Ye L, Zhang M, Jing X, Hong Y. Hui M, et al. Among authors: hong y. Biochem Biophys Res Commun. 2023 Oct 15;677:54-62. doi: 10.1016/j.bbrc.2023.08.004. Epub 2023 Aug 2. Biochem Biophys Res Commun. 2023. PMID: 37549602

8

Integrated lipid metabolomics and proteomics analysis reveal the pathogenesis of polycystic ovary syndrome.

Qian Y, Tong Y, Zeng Y, Huang J, Liu K, Xie Y, Chen J, Gao M, Liu L, Zhao J, Hong Y, Nie X. Qian Y, et al. Among authors: hong y. J Transl Med. 2024 Apr 17;22(1):364. doi: 10.1186/s12967-024-05167-x. J Transl Med. 2024. PMID: 38632610 Free PMC article.

9

The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.

Hong Y, Yin Y, Tan Y, Hong K, Zhou H. Hong Y, et al. Among authors: hong k. Med Sci Monit. 2019 Jan 13;25:395-401. doi: 10.12659/MSM.912341. Med Sci Monit. 2019. Retraction in: Med Sci Monit. 2023 Dec 07;30:e943403. doi: 10.12659/MSM.943403. PMID: 30636259 Free PMC article. Retracted.

10

Retracted: The Flavanone, Naringenin, Modifies Antioxidant and Steroidogenic Enzyme Activity in a Rat Model of Letrozole-Induced Polycystic Ovary Syndrome.

Hong Y, Yin Y, Tan Y, Hong K, Zhou H. Hong Y, et al. Among authors: hong k. Med Sci Monit. 2023 Dec 7;30:e943403. doi: 10.12659/MSM.943403. Med Sci Monit. 2023. PMID: 38059305 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

12,866 results

Search Page

Filters